Lemaitre Vascular (LMAT) Tops Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
LeMaitre Q4 2015 Record Sales $20.5mm (+14% organic), Record Net Income $2.5mm (+32%)
February 24, 2016 4:05 PM ESTBURLINGTON, Mass., Feb. 24, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, today reported Q4 2015 results, announced an increased dividend of $0.045/share and provided guidance.
Q4 2015 results included:
Record sales of $20.5mm, +10% reported (+14% organic) vs. Q4 2014Operating income of $3.1mm vs. $2.7mm, +13%Operating margin of 15%Record net income of $2.5mm vs. $1.9mm, +32%Record EPS of $0.13 per diluted share vs. $0.11, +25%Record EBITDA of $4.0mm vs. $3.6mm, +12%Cash increased $3.8mm to $27.5mmQ4 2015 sales of $20.5mm increased 10% (+14% organic) vs.... More
